Literature DB >> 16132367

Impact of the amount of excess solids on apparent solubility.

Kohsaku Kawakami1, Kyoko Miyoshi, Yasuo Ida.   

Abstract

PURPOSE: The impact of excess solids on the apparent solubility is examined.
METHODS: The apparent solubility of some model drugs was measured in various buffered solutions, with various amounts of excess solid. To help understand the dependence of the solubility on the amount of solid, we evaluated the dissolution and crystallization rates of indomethacin (IDM), one of the model drugs, at near-equilibrium conditions.
RESULTS: In the case of IDM, the apparent solubility decreased with an increase in the solid amount at pH 5 and 6. On the other hand, it increased with an increase in the solid amount at pH 6.5 and 7. The crystallization and dissolution rates of IDM decreased and increased, respectively, with an increase in pH values, and became equal at between pH 6 and 7. Therefore, the apparent solubility was most likely to be affected by the balance between the crystallization and dissolution rates. The apparent solubility of other model drugs showed the same trend, although the dependency on the solid amount was not as significant as in the case of IDM.
CONCLUSIONS: The apparent solubility was affected by the amount of solid for all the model drugs investigated. This was most likely to be caused by a competition between the crystallization and dissolution rates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132367     DOI: 10.1007/s11095-005-6247-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

Review 1.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

Authors:  R H Müller; C Jacobs; O Kayser
Journal:  Adv Drug Deliv Rev       Date:  2001-03-23       Impact factor: 15.470

Review 2.  High throughput physicochemical profiling for drug discovery.

Authors:  E H Kerns
Journal:  J Pharm Sci       Date:  2001-11       Impact factor: 3.534

Review 3.  Prediction of drug solubility from structure.

Authors:  William L Jorgensen; Erin M Duffy
Journal:  Adv Drug Deliv Rev       Date:  2002-03-31       Impact factor: 15.470

4.  Variability of dissolution rates at constant undersaturation.

Authors:  Malvina G Orkoula; Petros G Koutsoukos
Journal:  J Colloid Interface Sci       Date:  2002-09-01       Impact factor: 8.128

5.  Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding.

Authors:  M Otsuka; T Matsumoto; N Kaneniwa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-04       Impact factor: 1.645

6.  Studies on the crystalline form of phenytoin.

Authors:  S Chakrabarti; R van Severen; P Braeckman
Journal:  Pharmazie       Date:  1978-06       Impact factor: 1.267

7.  Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility.

Authors:  L Pan; Q Ho; K Tsutsui; L Takahashi
Journal:  J Pharm Sci       Date:  2001-04       Impact factor: 3.534

8.  Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.

Authors:  Kieran J Crowley; George Zografi
Journal:  J Pharm Sci       Date:  2002-02       Impact factor: 3.534

9.  Solubility of E2050 at various pH: a case in which apparent solubility is affected by the amount of excess solid.

Authors:  Zeren Wang; Lana S Burrell; William J Lambert
Journal:  J Pharm Sci       Date:  2002-06       Impact factor: 3.534

10.  Solubilization behavior of poorly soluble drugs with combined use of Gelucire 44/14 and cosolvent.

Authors:  Kohsaku Kawakami; Kyoko Miyoshi; Yasuo Ida
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

  10 in total
  4 in total

1.  Solubility of pioglitazone hydrochloride in binary and ternary mixtures of water, propylene glycol, and polyethylene glycols 200, 400, and 600 at 298.2 k.

Authors:  Abolghasem Jouyban; Shahla Soltanpour
Journal:  AAPS PharmSciTech       Date:  2010-11-30       Impact factor: 3.246

2.  Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  AAPS PharmSciTech       Date:  2008-01-19       Impact factor: 3.246

3.  Harmonizing solubility measurement to lower inter-laboratory variance - progress of consortium of biopharmaceutical tools (CoBiTo) in Japan.

Authors:  Asami Ono; Naoya Matsumura; Takahiro Kimoto; Yoshiyuki Akiyama; Satoko Funaki; Naomi Tamura; Shun Hayashi; Yukiko Kojima; Masahiro Fushimi; Hiroshi Sudaki; Risa Aihara; Yuka Haruna; Maiko Jiko; Masaru Iwasaki; Takuya Fujita; Kiyohiko Sugano
Journal:  ADMET DMPK       Date:  2019-08-05

4.  Novel Morpholine-Bearing Quinoline Derivatives as Potential Cholinesterase Inhibitors: The Influence of Amine, Carbon Linkers and Phenylamino Groups.

Authors:  Cheng Liu; Li-Ning Wang; Yu-Ming Liu
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.